Cargando…
Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’
Autores principales: | Higuchi, Susumu, Miyata, Hisatsugu, Hayashi, Takako |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064995/ https://www.ncbi.nlm.nih.gov/pubmed/31876051 http://dx.doi.org/10.1111/pcn.12971 |
Ejemplares similares
-
Nalmefene in alcohol‐dependent patients with a high drinking risk: Randomized controlled trial
por: Miyata, Hisatsugu, et al.
Publicado: (2019) -
Long‐term safety and efficacy of nalmefene in Japanese patients with alcohol dependence
por: Higuchi, Susumu, et al.
Publicado: (2020) -
Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene
por: Luquiens, Amandine, et al.
Publicado: (2014) -
Drinking Levels and Profiles of Alcohol Addicted Rats Predict Response to Nalmefene
por: Foo, Jerome Clifford, et al.
Publicado: (2019) -
Nalmefene and alcohol dependence: A new approach or the same old unacceptable marketing?
por: Braillon, Alain, et al.
Publicado: (2015)